NeuroPace develops and commercializes the RNS System, an FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity. This system is designed for adults with drug-resistant focal epilepsy, offering significant seizure reduction and improved quality of life through personalized stimulation and data-driven insights for physicians.